Poster Abstracts • OFID 2018:5 (Suppl 1) • S179 pharmacist-led, pre-authorization process. The antimicrobial stewardship team prospectively reviewed all adult CDI-PCR cases sent to the laboratory prior to specimen processing twice daily, 7 days a week to assess for clinical appropriateness based on guideline criteria. Bone marrow transplant and pediatric patients were excluded. If a patient lacked appropriate CDI clinical criteria, the provider was contacted to discontinue the PCR. CDI-PCR appropriateness was assessed for all patients with a CDI-PCR during the preceding year as a retrospective, comparative cohort. The primary objective was to assess appropriateness of the CDI-PCR pre-and postintervention. Secondary objectives included intervention sensitivity, specificity, safety, total CDIPCRs processed, and protocol adherence.
Background. Traditionally a healthcare-associated infection, Clostridium difficile infection (CDI) is increasingly emerging in communities. Health disparities in CDI exist, but the social determinants of health that influence community-associated (CA) CDI are unknown. We used factor analysis and disparate data sources to identify areabased socioeconomic status (SES) factors associated with CA-CDI incidence.
Methods. CDC's Emerging Infections Program conducts population-based CDI surveillance in 35 US counties. A CA-CDI case is defined as a positive C. difficile specimen collected as an outpatient or within 3 days of hospitalization in a person aged ≥1 year without a positive test in the prior 8 weeks or an overnight stay in a healthcare facility in the prior 12 weeks. 2014-2015 CA-CDI case addresses were geocoded to a 2010 census tract (CT) and incidence rates were calculated. CT-level SES variables were obtained from the 2011-2015 American Community Survey. The Health Resources and Services Administration provided medically underserved area (MUA) designations. Exploratory factor analysis transformed 15 highly correlated SES variables into threefactors using scree plot and Kaiser criteria: "Low Income, " "Foreign-born, " and "High Income. " To account for CT-level clustering, a negative binomial generalized linear mixed model was used to evaluate the associations of these factors and MUA with CA-CDI incidence, adjusting for age, sex, race and diagnostic test.
Results. Of 13,903 CA-CDI geocoded cases, 63% were female, 80% were white, and 36% were aged ≥65 years. Annual CA-CDI incidence was 63.4/100,000 persons. In multivariable analysis, "Low Income" (rate ratio [RR]: 1.09; 95% confidence interval [CI]: 1.05-1.13) and "High Income" (RR: 0.90; CI: 0.87-0.93) were significantly associated with CA-CDI incidence.
Conclusion. Factor analysis was instrumental in identifying key drivers of disparities among interrelated SES variables. Low-income areas were surprisingly associated with higher CA-CDI incidence, given that known CDI risk factors include increased access to healthcare. Understanding how SES factors might impact CA-CDI incidence can inform prevention strategies in low-income areas.
Disclosures.G. Dumyati, Seres: Scientific Advisor, Consulting fee. Results. Of 2,660 patients, 19 and four patients with confirmed and presumptive CDAD, respectively, were identified with an incidence of 2.76/10,000 (95% CI: 1.75-4.15) occupied bed days. Sixteen (70%) had blast injuries, four had gunshot wounds, and threehad other injuries. Median age was 24 years (IQR 23, 31). Median injury severity score was 38 (IQR 26, 47). Severe and fulminant CDAD was diagnosed in 8 (35%) and six (26%), respectively. Patients had a median hospitalization of 12 days (IQR 9.5, 34) and threeOR visits (IQR 2, 6) prior to CDAD diagnosis. Nineteen (83%) patients were in the ICU and 17 (74%) were intubated prior to or upon diagnosis. Seventeen patients had ≥1 infection before CDAD diagnosis, largely pneumonia (47%) and skin and soft-tissue infections (47%). Most patients (96%) were on antibiotics pre-CDAD diagnosis: first generation cephalosporins (1GC; 96%), tetracyclines (87%), vancomycin (74%), carbapenems (70%), and fluoroquinolones (FQ; 57%). Five (22%) received clindamycin. Of the 2637 patients without CDAD, 91% received antimicrobials during hospitalization (86% a 1GC, 47% FQ, and 16% clindamycin). Median length of hospital stay after CDAD diagnosis was 34 days (IQR 16, 55) . Treatment included only oral metronidazole in 15 patients, IV metronidazole in 2, and some combination of oral vancomycin, metronidazole, and IV metronidazole in 6. No patients died.
Clinical Characteristics of Military Trauma Patients With
Conclusion. Despite high rates of antimicrobial usage in this severely injured population, CDAD was uncommon. Though CDAD was severe or fulminant in >50%, no patients died.
Disclosures. All authors: No reported disclosures. Thursday, October 4, 2018: 12:30 PM Background. Current definitions for severe C. difficile infection (CDI) are based on populations of Western countries. We examined the predicting performance of existing definitions in Taiwanese population and developed a new severity score.
A Severity Score for Predicting In-Hospital Death in Patients With
Methods. We included adult patients who were admitted to China Medical University Hospital and had first-time positive C. difficile culture or toxin test during 2012-2016. The index date was the sampling date of the specimen. Data were pulled from the electronic medical records. The primary outcome was in-hospital death during the index admission. Variables that were significantly associated with in-hospital death in the bivariable analyses were included in a multivariable logistic regression model. We assigned weight for each variable using the adjusted odds ratio (aOR) and summed up the weights to obtain a severity score.
Results. Of 544 patients, median age was 71 years old and 70 patients (12.9%) died during the index admission. Patients did not differ in: gender, age, prior infection (−30 to 0 day of index date), prior admission, prior anti-peptic ulcer medication use, index (−3 to 3 days) glucose and kidney function except for blood urea nitrogen (BUN). Variables included in the multivariable model were: complicated diabetes (aOR 2.0; 0.8-5.2), malignancy (2.0; 1.1-3.7), prior use of second-generation cephalosporins (1.8; 0.9-3.7), use of loperamide (1.8; 1.0-3.4) or probiotics within −14 to 14 days (2.4; 1.0-5.5), index white blood cell count (WBC) > 15,000 cells/μL (1.9; 1.0-3.6), index serum creatinine (sCr) ≥1.5 times premorbid level (1.1; 0.6-2.1), index BUN >30 mg/ dL (1.7; 0.9-3.5), and index BUN/sCr ratio > 20 (1.3; 0.7-2.5). The severity score was
